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1. Curriculum Vitae 
 
 Prof Finlay works part-time at Cardiff University where he supervises PhD students, 
writes, manages the use of quality of life measures internationally and lectures. But most of 
the time he tries to be retired. 
 Year of birth: 1948, Hillingdon, UK. He ǁas a ŵediĐal studeŶt at “t MarǇ’s Hospital 
Medical School in London, where (not when) Fleming discovered penicillin. He later trained 
in London, Cardiff and Miami.  His first consultant job was in Glasgow, Scotland. 
 Prof Finlay has authored over 400 publications and has lectured widely 
internationally. He is currently co-authoring the second edition of an undergraduate 
dermatology textbook, Dermatology at a Glance.   With Ronnie Marks, he co-founded and 
edited the still thriving Journal of Dermatological Treatment.  His early research interest was 
on nail pharmacokinetics, but he grew bored with this and over the last 30 years his main 
focus has been on developing, validating and using quality of life measures. Recently he has 
been exploring how dermatologists are influenced when taking clinical decisions. 
 As a clinical teacher and educator he has been director of full time and part time 
Dermatology postgraduate diploma and degree courses. He was appointed to be Professor 
of Dermatology at Cardiff University in 1999 and was later also clinical director.  He retired 
as Head of Department in 2009. 
 
 2. What brought you to Dermatology? 
 
At medical school I wanted to become a bacteriologist.  But later, when a junior pathologist, 
I was put off (in a big way) by not getting on with the Professor of Bacteriology.  In any case I 
was missing clinical contact and so decided to go back to general medicine.  On the first day 
in my new job I was told ͞By the way, on Wednesday afternoons you help with the 
derŵatologǇ ĐliŶiĐ at the Meŵorial Hospital͟.  I sooŶ fouŶd this the ďest ďit of the ǁeek aŶd 
was infected by the enthusiasm of Dr Woolfson, the local dermatologist.  So the decision to 
do dermatology became easǇ.  I’ǀe Ŷeǀer regretted this choice, in fact I caŶ’t uŶderstaŶd 
why any doctor would want to do any other specialty. 
 
 
3. Who were your most important teachers?  
 
Ronnie Marks was my boss, then close collaborator and colleague over 40 years.  He taught 
me to develop new ideas, to set up new ventures, to write scientific papers and to think 
outside the box.  He also taught me the central importance of being able to measure things 
in dermatology. 
 
Peter Holt was also first my boss and then a colleague.  Peter lived the concept of a 
dermatologist being a physician first, with a special extra expertise in dermatology, a great 
role model.  The wide general medical knowledge that he always brought to the 
investigation, management and care of his patients was greatly to their benefit, and taught 
me not to lose touch with our general medical roots. 
 
4. From whom did you learn most? 
 
My father Harry Finlay was a paediatrician, for many years single handedly covering a huge 
population.  I learnt (but never equalled) his habits of constantly enquiring and looking up 
about clinical problems and his unflagging interest in his specialty.  However I also 
experienced at first hand this devotion to clinical duty eating into his personal life and so 
have tried, mostly unsuccessfully, to have a better work/life balance.  Harry had severe 
chronic atopic eczema throughout his life: this was a major influence on my interest in 
quality of life issues for the patient and gave me insight into the family burden of skin 
disease. 
 
 
5. Please list your 5 best publications: 
 
It depends ǁhat Ǉou ŵeaŶ ďǇ ͞ďest͟. The oŶes that I’ŵ proudest of are: 
Finlay AY, Khan GK.  Dermatology Life Quality Index (DLQI) - a simple practical measure for 
routine clinical use.  Clinical and Experimental Dermatology, 1994; 19: 210-216. 
This manuscript was rejected by the BJD, probably correctly, because by following the 
referees’ suggestions we did improve it. It is now one of the highest cited clinical 
dermatology papers ever. I recently was delighted to re-establish contact with my old PhD 
student Dr Khan, now working in the UAE: we chatted as if it was only yesterday that we 
worked together. 
 
Hongbo Y, Thomas CL, Harrison MA. Salek MS, Finlay AY. Translating the science of quality 
of life into practice:  what do Dermatology Life Quality Index scores mean? Journal of 
Investigative Dermatology 2005; 125: 659-664. 
This paper was critical in turning the DLQI into a useful clinical tool.  I later visited Dr Hongbo 
in Wuhan, where Chairman Mao famously swam across the Yangtze river in 1966. 
 
Finlay AY.  Current severe psoriasis and the Rule of Tens.  British Journal of Dermatology 
2005; 152: 861-867.  This concept placed, for the first time at least in Dermatology, a 
measure of quality of life impact within the definition of disease severity.  The rule’s 
influence on guideline criteria for biologic use in psoriasis has made dermatologists in many 
countries give more attention to quality of life issues.  
 
Basra MKA, Sue-Ho R, Finlay AY.  The Family Dermatology Life Quality Index:  measuring the 
secondary impact of skin disease.  British Journal of Dermatology 2007; 156: 528-538 
The impact that skin disease has on the partner and other family members is a massive 
burden that is usually ignored.  The FDLQI questionnaire, by measuring impact, focuses 
attention on it. 
 
Finlay AY, Marks R.  An hereditary syndrome of lumpy scalp, odd ears and rudimentary 
nipples.  British Journal of Dermatology, 1978; 99: 423-430. 
This is the only new condition that I discovered. By chance a patient with this syndrome 
came into my clinic very soon after I started as a junior dermatology trainee. I assumed that 
my experienced seniors would recognise it, but it turned out to be a first.  It now has a 
McKusick OMIM number and the underlying gene defect of KCTD1 missense mutations 
 was recently identified. 
 
Finlay AY, Edwards PH, Harding KG.  "Fingertip unit" in dermatology.  Lancet, 1989; II, 155. 
We thought of the Fingertip Unit one Sunday afternoon when, in a deserted dermatology 
outpatients clinic, we were trying to film an educational programme for GPs. Instead of 
dismissing the thought, I went to the lab the next day, got 20 volunteers to squeeze out 
ointment onto their fingertips and weighed it, establishing that one FTU weighs about half a 
gram. Colin Long and I then had fun discovering that this covers about 2% of the body 
surface (two handprints). 
 
 
6. Have you ever been president or in the leadership of an academic society? 
 
I was elected, by the membership, as President of the British Association of Dermatologists 
back in 2001.  I hugely enjoyed being at the centre of British Dermatology in this and other 
committee chairman roles. I was constantly impressed by the willingness of so many 
colleagues to devote time and energy to the wellbeing of their colleagues and the 
development of our specialty.   
 
7. What was your greatest achievement in your professional life? 
 
I think my greatest achievement has been to contribute, at least in a small way, to a shift in 
thinking in dermatology, turning the specialty away from being doctor-centred to being 
primarily patient-centred. Specifically, our work creating simple questionnaires to measure 
the impact of skin disease on quality of life, has helped to move attitudes towards treating 
the patieŶt’s eǆperieŶĐe ǁith iŶterest aŶd respeĐt, and of value in informing clinical 
decisions. 
 
A close-run thing with the above has been the influence of our teaching programmes on 
improving the management of skin diseases in general practice.  Over 4,000 GPs have taken 
the one-year distance learning Diploma in Practical Dermatology that I designed in 1987, and 
many more have completed similar courses inspired by ours.  This has had a profound 
impact on the quality of care received by countless patients. 
 
And, of course, I’ǀe ďeeŶ iŵŵeŶselǇ proud of, and humbled by, the recognition of my peers, 
for example receiving last year the British Society of Investigative Dermatology Medal, and 
receiving the anachronistically titled ͞Commander of the British Empire͟ medal (CBE) from 
Queen Elizabeth II for ͞services to medicine͟. I’ŵ still Ŷot sure ǁhiĐh part of the Eŵpire I’ŵ 
meant to be commanding. 
 
I get the biggest kick from coming up with new ideas, throwing them out into world and 
seeiŶg ǁhat happeŶs to theŵ.  This is reallǇ the studǇ of ͞ŵeŵes͟, ideas aŶd ĐoŶĐepts 
viewed as living organisms, capable of reproducing and evolving.  Some ideas are very 
successful, taking on a life of their own (e.g. Rule of Tens; DLQI). Some (most) drop dead (e.g. 
nail flexibility measurement; the new word quimp).  And some lie dormant for many years 
and then gradually get accepted and used (Partner/family quality of life/the Greater Patient; 
training for outpatient discharge).  I find it hugely satisfying when ideas do emerge from 
hibernation years later.  
 
It should be emphasised that all of my research and teaching has only been possible because 
of a series of teaŵ efforts.  Although this artiĐle is aďout ͞ŵe͟, ŵaŶǇ Đolleagues equally 
deserve full recognition.   
 
 8. What was your greatest disappointment in your professional life? 
 
Life’s too short to ďe ďurdeŶed ďǇ disappoiŶtŵeŶts.  I’ŵ alǁaǇs too ďusǇ ǁith the Ŷeǆt tasks 
to spend any time brooding over what might have been.  There have been many ventures 
that have failed but I console myself by branding them ͞ideas ahead of their time͟. There 
have been failed spinoff educational companies, failed grant applications, failure to ever 
publish a book on which hundreds of hours were wasted, failures to be appointed to junior 
and to consultant jobs, failures to manage staff as well as I should, failures to submit 
manuscripts for publication and vast numbers of rejected abstracts and manuscripts. None 
stands out in particular, eǆĐept…… 
 
As a medical student I was fascinated by the possibility of computer aided diagnosis. In a one 
year project I proposed ways to calculate the probability of diagnoses based on a formula 
that included current and prior probability data.  I was extremely excited for weeks when I 
worked out an equation that I thought would revolutionise computer diagnosis in medicine.  
I caŶ still feel the elatioŶ of ŵǇ ͞disĐoǀerǇ͟.  “o ŵǇ ďiggest disappoiŶtŵeŶt, ǁhiĐh I also still 
feel 50 years later, was to later discover that the theorem had been published by Bayes in 
1763.  I was a little late.  The moral is, always do a thorough literature review (but I still got 
the medical school prize for the project). 
 
Regrets are slightly different from disappointments.  I do regret not fully focussing my efforts 
on quality of life: we could have achieved more.  I also regret some aspects of the process of 
restructuring the dermatology department when I took over as head: I could have acted in a 
more effective way.  
 
 
9. What was your most funny experience in your professional life? 
 
When recounted years later, most funny experiences end with the apologǇ ͞Well it was 
funny  at the tiŵe͟.  Our aŶŶual fun-filled Christmas dermatology parties, held in an over-
decorated outpatients’ department decades before the dawn of political correctness, 
required staff to come in fancy dress.  My star turn as a 250mm punch biopsy represented 
the peak of my expertise in dermatology surgery. 
 
 
10. Whom would you list among the top ten dermatologists (please name only  
deceased persons): 
 
Steve Katz 
A giant of US medicine, who hugely enhanced the status of dermatology 
 
Bernie Ackerman 
A captivating teacher 
 
Neil  Cox  
A superb teacher with a broad ranging intellect who demonstrated with huge energy that it 
is possible to contribute outstandingly academically from a position as a dermatologist in a 
general hospital. 
 
Robert Willan 
His disease classification finally made sense out of chaos. 
 
 
11. Whom would you list among the top ten of living dermatologists? 
 
To be in the Top Ten you should not only be a great clinical dermatologist and researcher, 
but also an original thinker with wide influence. So in alphabetical order: 
Steve Feldman, Lionel Fry, Chris Griffiths, Gregor Jemec, Peter van de Kirkhof, Rona Mackie, 
Robin Marks, Ronnie Marks, Terence Ryan and Hywel Williams. 
 
 
12. What will be the greatest problem for Dermatology in the next ten years? 
 
Key problems facing Dermatology include, in the developed world, the appropriate 
integration of multiple new and very expensive therapies into clinical practice. There are also 
growing ethical issues resulting from the perfect storm of multiple unvalidated cosmetic 
intervention techniques, the need/desire of dermatologists for income, the uncritical public 
demand for cosmetic intervention and the insufficiently regulated cosmetic environment. 
In stark contrast, the lack of even basiĐ derŵatologǇ Đare for ŵuĐh of the ǁorld’s populatioŶ 
remains a major humanitarian issue. 
 
 
13. What will be the next breakthrough in the coming ten years in Dermatology? 
 
Therapeutically, possibly the advent of effective treatment for some of the most resistant 
inflammatory skin conditions, such as lichen planus. I think we will also see a maturing of the 
huge research focus on hidradenitis suppurativa into clinical strategies to transform the lives 
of patients. 
 
However the ŵost eǆĐitiŶg ͞ďreakthrough͟ will be the reality of Artificial Intelligence being 
applied to diagnosis and management advice in clinical dermatology.  Some shudder at the 
thought of our visual diagnostic skills being eclipsed and the subsequent death of some 
aspects of traditional dermatology.  But we should embrace the fantastic potential of these 
new approaches, while ensuring that they are underpinned by research evidence. The role 
and responsibilities of clinical dermatologists will continue to evolve, just as they have over 
the last 200 years, but at an ever-increasing rate of change.  One thing we can be sure of, 
patients will need even more to have the balanced informed expertise and empathic wisdom 
of a kind and understanding dermatologist. 
 
 
Conflict of interest 
AYF is joint copyright owner of the DLQI, FDLQI and other measures.  Cardiff University and 
AYF receive royalties. 
 
 
  
 
 
